---
title: Publications from the Wang Lab
layout: default
group: publications
---


# Publications


Full pulblication list in [ORCID](https://orcid.org/0000-0002-8566-875X) and [Google Scholar](https://scholar.google.com/citations?user=9ankzb4AAAAJ&hl=en&oi=ao)

---
1. Xiang W, Lu H, Shen A, Ni H, **Wang Y**. Nuclear β-adrenergic signaling microdomain alleviates diabetic kidney fibrosis by YAP inactivation. British Journal of Pharmacology (In revision).

1. **Wang Y**, Zhao M, Liu XH, Xu B, Rivera G, Xiang YK. Carvedilol Activates a Myofilament Signaling Circuitry to Restore Cardiac contractility in Heart failure. JACC: Basic to Translational Science (Accpted).

1. Fu Q, **Wang Y**, Yan C, Xiang YK. Phosphodiesterases in heart and vessels- From Physiology to Diseases. Physiol Rev. 2023.

1. Bing Xu, **Ying Wang**, Chaoqun Zhu, Meimi Zhao, Yu Zhang, Bingqing Deng, Zhenduo Zhu; Qiuyun Guan, Nipavan Chiamvimonvat, Qingtong Wang, and Yang K. Xiang. Differential downregulation of subcellular specific beta1-adrenergic receptor signaling in the heart. Journal of the American Heart Association (Accpted). 

1. Wenjing Xiang1\*, Xingyun Wang1\*, Lei Li1, Junhui Zeng1, Haocheng Lu1&, Ying Wang1&, Unveiling Catecholamine Dynamics in Cardiac Health and Disease: Mechanisms, Implications, and Future Perspectives. International Journal of Drug Discovery and Pharmacology 2023.

1. Xiang W, Zhou N, Li L, Chen F, Li L, **Wang Y**. βIV-Spectrin in Cardiac Fibroblasts: Implications for Fibrosis and Therapeutic Targeting in Cardiac Diseases. Comment on Nassal et al. Spectrin-Based Regulation of Cardiac Fibroblast Cell-Cell Communication. Cells 2023, 12, 748. Cells. 2023;12:2186.

1. Deng BQ\*, Zhang Y\*, Zhu CQ\*, **Wang Y**, Weatherford E, Xu B, Conway S, Abel ED, and Xiang YK. Divergent actions of myofibroblast and myocyte beta2-adrenoceptor signaling in heart failure and fibrotic remodeling. Circ Res. 2022 Dec; DOI: 10.1161/CIRCRESAHA.122.321816
 
1. Lu, H., Zhang, C., Li, Y. and **Wang, Y.** (2022), Mitochondria dysfunction in the failing right heart: what is the potential therapeutic target?. J Physiol. Accepted Author Manuscript. https://doi.org/10.1113/JP283977

1. **Wang Y**, Zhao M, Xu B, Bahriz SMF, Zhu C, Jovanovic A, Ni H, Jacobi A, Kaludercic N, Di Lisa F, Hell JW, Shih JC, Paolocci N, Xiang YK. Monoamine oxidase A and organic cation transporter 3 coordinate intracellular β1AR signaling to calibrate cardiac contractile function. Basic Res Cardiol. 2022;117:37   

1. **Wang Y**, Zhao M, Shi Q, Xu B, Zhu C, Li M, Mir V, Bers DM, Xiang YK. Monoamine Oxidases Desensitize Intracellular β1AR Signaling in Heart Failure. Circ Res. 129 (10), 965-967.   

1. **Wang Y\***, Shi Q\*, Li M, Zhao M, Reddy GR, Teoh JP, Xu B, Zhu CQ, Ireton KE, Srinivasan S, Chen SL, Gasser PJ, Bossuyt J, Hell JW, Bers DM, Xiang YK. Intracellular β1-Adrenergic eceptors and Organic Cation Transporter 3 Mediate Phospholamban Phosphorylation to Enhance Cardiac Contractility. Circ Res. 2020 Nov; DOI: 10.1161/CIRCRESAHA.120.317452.   

1. Wang Q, **Wang Y**, West TM, Liu Y, Reddy GR, Barbagallo F, Xu B, Shi Q, Deng B, Wei W, Xiang YK. Carvedilol induces biased β1 adrenergic receptor-Nitric oxide synthase 3-cyclic guanylyl monophosphate signaling to promote cardiac contractility. Cardiovasc Res. 2020 Sep 21; doi: 10.1093/cvr/cvaa266.  

1. Xu B, Li M, **Wang Y**, Zhao M, Morotti S, Shi Q, Wang Q, Barbagallo F, Teoh JP, Reddy GR, Bayne EF, Liu Y, Shen A, Puglisi JL, Ge Y, Li J, Grandi E, Nieves-Cintron M, Xiang YK. GRK5 Controls SAP97-Dependent Cardiotoxic β1 adrenergic receptor-CaMKII signaling in heart failure. Circ Res. 2020 Aug 28;127(6):796-810. doi: 10.1161/CIRCRESAHA.119.316319.   

1. Reddy GR, West TM, Jian Z, Jaradeh M, Shi Q, **Wang Y**, Chen-Izu Y, Xiang YK. Illuminating cell signaling with genetically encoded FRET biosensors in adult mouse cardiomyocytes. J Gen Physiol. 2018 Nov 5;150(11):1567-1582. doi: 10.1085/jgp.201812119.     

1. **Wang Y**, Cao Y, Zhu Q, Gu X, Zhu YZ. The discovery of a novel inhibitor of apoptotic protease activating factor-1 (Apaf-1) for ischemic heart: synthesis, activity and target identification. Sci Rep. 2016 Jul 22;6:29820.   

1. **Wang Y**, Zhong L, Liu X, Zhu YZ. ZYZ-772 Prevents Cardiomyocyte Injury by Suppressing nox4-derived ROS production and apoptosis. Molecules. 2017 Feb 21;22(2). doi: 10.3390/molecules22020331.aax8286. doi: 10.1126/sciadv.aax8286. PMID: 32064340; PMCID: PMC6989145.    

1. **Wang Y**, Zhang Q, Zhong L, Lin M, Luo X, Liu S, Xu P, Liu X, Zhu YZ. Apoptotic Protease activating factor-1 inhibitor mitigates myocardial ischemia injury via disturbing procaspase-9 recruitment by Apaf-1. Oxid Med Cell Longev. 2017;2017:9747296.

1. Zhang QY, Wang ZJ, Miao L, **Wang Y**, Chang LL, Guo W, Zhu YZ. Neuroprotective Effect of SCM-198 through stabilizing endothelial cell function. Oxid Med Cell Longev. 2019;2019:7850154.   

1. Zhang QY, Wang ZJ, Sun DM, **Wang Y**, Xu P, Wu WJ, Liu XH, Zhu YZ. Novel Therapeutic effects of leonurine on ischemic stroke: New Mechanisms of BBB Integrity. Oxid Med Cell Longev. 2017;2017:7150376.  

1. Xu B, **Wang Y**, Bahriz SMFM, Zhao M, Zhu C, Xiang YK. Probing spatiotemporal PKA activity at the ryanodine receptor and SERCA2a nanodomains in cardomyocytes. Cell Commun Signal. 2022 Sep 14;20(1):143.   
{: reversed="reversed"}





